Management of malignant glioma--quo vadis?
Data(s) |
2008
|
---|---|
Identificador |
https://serval.unil.ch/notice/serval:BIB_1457A298DB74 info:pmid:18547969 doi:10.1159/000134024 pmid:18547969 isiid:000256623000002 |
Idioma(s) |
eng |
Fonte |
Onkologie316300-302 |
Palavras-Chave | #Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemotherapy, Adjuvant; Dacarbazine; Glioma; Humans; Treatment Outcome |
Tipo |
info:eu-repo/semantics/article article |